Ausgewählte Transaktionen
To reflect healthcare trailblazers, we are shifting our focus to an integrative healthcare approach from therapeutics to personalized and preventive medicine, anti- and better-aging, healthy well-being and lifestyle.
Please find below selected transactions completed by WINDOME BANKING PARTNERS‘ employees while at other Firms, except for the Suisselle-Sihuan Pharma Deal (June 2023).
Lead Financial advisor to Bayer AG in their preparation of the acquisition of Aventis CropScience and completion of a detailed fairness opinion on alternative strategic options.
Exclusive advisor for the acquisition of the Californian Plasma Fractionation Company SeraCare’s 43 US blood transfusion and collection centers.
Exclusive financial advisor to Lion bioscience AG, a global leader in bio-informatics in the acquisition of US-based private company NetGenics Inc.
Exclusive financial advisor to Teva in the issuance of a convertible bond offering.
Exclusive financial advisor to IVAX Corporation in their acquisition of Chile-based Laboratorio Chile S.A.
Exclusive advisor to BASF AG on the divestment of their global plastic Colorants‘ Business, a transaction involving 11 sites globally and the carve-out of the Headquarters’ support function.
Exclusive Financial Advisor in the acquisition of DSM N.V.‘s Transparent Sheet Business, a cross-border transaction involving two production sites.
Exclusive Financial Advisor for the issuance of equity instruments (SWORD: Stock Warrant Off-Balance-Sheet R&D vehicle), consisting in the demerger of Central Nervous System assets.
Exclusive Financial Advisor in the acquisition of the Swedish Industrial Gas Corporation AGA.
Exclusive Financial Advisor to Tobaccoland GmbH & Co KG, in the combination via merger of their cigarette manufacturing and distribution activities with Austria Tabak.
Exclusive Financial Advisor to VIAG on the sale of their Chemicals Distribution Kloeckner Chemie to mg Technologies.
Exclusive Financial Advisor in the review of German Targets and the acquisition of a majority equity stake in Schwarz Pharma.